Generic Name and Formulations:
Bisoprolol (as fumarate) 5mg+, 10mg; tabs; +scored.
Indications for ZEBETA:
5mg once daily; max 20mg once daily. Renal or hepatic dysfunction, or bronchospastic disease: initially 2.5mg once daily.
Cardiogenic shock. Overt heart failure. 2nd- or 3rd-degree AV block. Marked sinus bradycardia.
CHF. Angina. Peripheral vascular disease. Asthma. COPD. Surgery. Diabetes. Thyroid disease. Hepatic or renal impairment. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers.
Additive effects with reserpine, guanethidine, other catecholamine depleting drugs, calcium channel blockers, antiarrhythmics, myocardial depressants. Increased rebound hypertension with clonidine withdrawal. Antagonized by rifampin. May block epinephrine.
Headache, fatigue, GI upset, upper respiratory symptoms (eg, cough, dyspnea, rhinitis), chest pain.
Sign Up for Free e-newsletters
- Chemotherapy-Related Fatigue Linked to Levothyroxine Use in Breast Cancer
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Obesity, Male Gender May Improve Survival Outcomes with Targeted and Immunotherapy in Melanoma
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Apalutamide Prolongs Time to Metastasis in Castration-resistant Prostate Cancer
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
- Zinc Sulfate Improves Chemotherapy-Induced Mucositis Outcomes in Leukemia
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Travel Distance to Prostate Cancer Treatment Influences Treatment Choice
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|